SGTI- Femalgen

It is estimated that over 12 million Americans suffer from urinary incontinence (UI). For many people, UI affects their emotional, psychological, and social well-being. Women are affected by the disorder more frequently than men. Older women are more prone to UI; approximately twenty percent of women over age 65 are incontinent. Incontinence from the loss of bladder control is treatable and often curable at all ages.

Femalgen™ is a cutting-edge nutraceutical comprised of soybean germ and pumpkin seed extracts. Femalgen™ has been clinically shown to support healthy, normal bladder function and control.

In an open clinical trial on 39 postmenopausal women aged 52 to 86 years, who reported two or more micturition episodes (the passage of urine) during the night, received a total of 10 tablets daily, which provided 875 mg pumpkin seed extract and 167 mg soybean germ extract during the first two weeks.

By the third week of the study, the dosage was decreased to 6 tablets per day with a corresponding decrease in the active ingredients to 525 mg and 100 mg, respectively. The daily tablets were divided into two doses, in the morning and evening.

FemalgenT markedly improved the frequency of urination during the night and daytime after the first week, followed by continuing improvement at the second week, and no further improvement after the fourth week. The frequency of urinary incontinence was also improved at week 2, and markedly improved at week 4.

FemalgenT helps combat the debilitating symptoms of urinary incontinence.

Hide Science



	It is estimated that over 12 million Americans suffer from urinary incontinence (UI). For many people, UI affects their emotional, psychological, and social well-being. Women are affected by the disorder more frequently than men. Older women are more prone to UI; approximately twenty percent of women over age 65 are incontinent. Incontinence from the loss of bladder control is treatable and often curable at all ages. Femalgen™ is a cutting-edge nutraceutical comprised of soybean germ and pumpkin seed extracts. Femalgen™ has been clinically shown to support healthy, normal bladder function and control. View Science In an open clinical trial on 39 postmenopausal women aged 52 to 86 years, who reported two or more micturition episodes (the passage of urine) during the night, received a total of 10 tablets daily, which provided 875 mg pumpkin seed extract and 167 mg soybean germ extract during the first two weeks. By the third week of the study, the dosage was decreased to 6 tablets per day with a corresponding decrease in the active ingredients to 525 mg and 100 mg, respectively. The daily tablets were divided into two doses, in the morning and evening. FemalgenT markedly improved the frequency of urination during the night and daytime after the first week, followed by continuing improvement at the second week, and no further improvement after the fourth week. The frequency of urinary incontinence was also improved at week 2, and markedly improved at week 4. FemalgenT helps combat the debilitating symptoms of urinary incontinence. Hide Science





	Home \| Who We Are \| Products \| Services \| Conventions \| Education \| Contact